Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder. Ronquest NA, Willson TM, Montejano LB, Nadipelli VR, Wollschlaeger BA. Subst Abuse Reh…

High buprenorphine-related mortality is persistent in Finland. Kriikku P, Häkkinen M, Ojanperä I. Forensic Sci Int. 2018 Aug 17;291:76-82. doi: 10.1016/j.forsciint.2018.08.010.  Abstract https://www.sciencedirect.com/science/artic…

Buprenorphine Formulations for the Treatment of Opioid Use Disorders: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness and Guidelines [Internet]. Harricharan S, Farah K. Ottawa (ON): Canadian Agency for Drugs and Technologies in…

MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study. Schuman-Olivier Z, Bo…

USA. OxyContin maker gets patent for drug to treat opioid addiction Purdue Pharma, the maker of OxyContin, has received a patent designed to treat opioid addiction. The patent, first reported by The Financial Times, is for a new and faster-acting…

USA. FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence Agency is taking additional steps to advance the development of new FDA-approved treatments for opioid dependence and…